Bio Essence Corp (OTC: BIOE) is a California-based health supplements and pharmaceutical products company that sells goods on a transactional basis, recognizing revenue at point of delivery under ASC 606. The company is headquartered at 17506 Colima Road, City of Industry, CA 91748, and was incorporated in California on January 1, 2000. Its subsidiaries have included Bio Essence Pharmaceutical, Inc. (BEP), Bio Essence Herbal Essentials Inc. (BEH), and McBE Pharma, Inc. (McBE), though BEH has been disposed of and McBE dissolved as of the 10-K filed March 27, 2026. The company reported a net income of $896,197 from continuing operations for FY2025, following a net loss of $1,565,721 in FY2024, and carried an accumulated deficit of $9,553,073 from continuing operations as of December 31, 2025. The auditor issued a going concern qualification. Internal controls over financial reporting were assessed as not effective as of December 31, 2025. CEO is Yin Yan; CFO is William Sluss.

Revenue model

Transactional product sales, with revenue recognized at point of delivery per ASC 606. No subscription or royalty model is disclosed in the filing excerpts.

Products and services

Health supplements, traditional Chinese medicines (single herbs, granules, pills, tablets), formulated dietary supplements, medical food, and original equipment manufacturing and private label pharmaceutical processing services, based on historical subsidiary operations described in the 10-K filed March 27, 2026.

Customers and end markets

The filing excerpts do not disclose specific customer names, customer counts, or end-market segment breakdowns.

Value-chain role

Manufacturer and seller of health supplement and pharmaceutical products, with prior OEM and private label manufacturing services for third parties. As of the filing dated March 27, 2026, the company is also a defendant in litigation alleging breach of laboratory and pharmaceutical processing service obligations, with $1,504,823.81 in damages sought by Stason Industrial Corporation and Stason Pharmaceuticals, Inc.

Geographic exposure

Headquartered in City of Industry, California. The functional and reporting currency is U.S. dollars. No international revenue breakdown is disclosed in the filing excerpts.

Source: SEC 10-K, filed 2026-03-27

Industry: Pharmaceutical Preparations